Abstract
Introduction: The biological mechanisms linking mild cognitive impairment (MCI) and major depressive disorder are not well understood. We investigated whether molecular senescence changes in older adults are associated with a history of major depressive disorder (MDD) or MCI. Methods: We included 371 participants: 167 with MCI; 62 cognitively normal with a history of MDD; 97 with MDD+MCI; and 45 cognitively unimpaired (CU) without a history of MDD. The candidate Senescence-Associated Secretory Phenotype (SASP) biomarkers were measured in the plasma using a customized LUMINEX assay. Results: The MDD+MCI group had a higher SASP index than the other groups (P
Cite
CITATION STYLE
Diniz, B. S., Vieira, E. M., Mendes-Silva, A. P., Bowie, C. R., Butters, M. A., Fischer, C. E., … Rajji, T. K. (2021). Mild cognitive impairment and major depressive disorder are associated with molecular senescence abnormalities in older adults. Alzheimer’s and Dementia: Translational Research and Clinical Interventions, 7(1). https://doi.org/10.1002/trc2.12129
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.